Dr. Zhou Wenlai, Chairman and CEO of Danatlas, was invited to attend the 6th SIT 2024 Innovation Summit on Small Molecule Drugs and Peptide Drugs

Time:2024-03-28

From March 21st to 22nd, 2024, the "SIT 2024 6th Innovation Summit on Small Molecule Drugs and Peptide Drugs" was officially held in Shanghai. Danatlas Dr. Zhou Wenlai, Chairman and CEO, was invited to attend the summit.

At the summit, Dr. Zhou shared Danatlas's progress in the research and development of a new generation of synthetic lethal anti-tumor drugs. He also shared his insights on small molecule drug R&D during a panel discussion and exchanged ideas with his peers.

Danatlas will unswervingly carry out its mission of "developing innovative drugs with sincerity and bringing hope for human health!"

                        63fcbded61dd6b9d_html_bf9e099e2f69ce13      63fcbded61dd6b9d_html_8fa398d2122809a

DANATLAS US PHARMACEUTICALS, INC Office Address: 154 Wells Ave, Newton, MA 02459

business licence